Hepatitis B in the vaccine era: persistent burden and clinical implications
Clinical and Experimental Vaccine Research · 2026 · 15 (3) · 187
DOI: 10.7774/cevr.2026.15.e18 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Vaccine Research, 2026. Verfasst von Cherechi Nwabueze und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, John H. Stroger Hospital of Cook County, Chicago, IL, USA. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hepatitis B virus (HBV) infection remains a leading global cause of advanced liver disease and imposes a substantial economic burden. Early prevention is critical, as perinatally acquired HBV carries a high risk of progression to cirrhosis or hepatocellular carcinoma (HCC). Hepatitis B vaccination has been proven effective in preventing cancer, yet coverage of the complete vaccine series remains suboptimal. This implementation gap perpetuates the clinical burden, manifesting decades later as hepatic decompensation and liver cancer. This narrative review synthesizes the current HBV landscape, highlighting how gaps in vaccination policy and delivery contribute to real-world gastrointestinal outcomes. By reframing HBV vaccination as a core component of gastrointestinal and hepatology practice, clinicians can play a pivotal role in preventing cirrhosis and HCC while improving population health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, John H. Stroger Hospital of Cook County, Chicago, IL, USA.
- Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
- Department of Internal Medicine, University of Texas Rio Grande Valley School of Medicine, Edinburg, TX, USA.
- Department of Internal Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria.
ORCID-Profile: Cherechi Nwabueze, Eunice Omeludike, Ridwan Lawal, Kedife Nwabueze
Zitieren
APA
Nwabueze, C., Omeludike, E., Lawal, R., & Nwabueze, K. (2026). Hepatitis B in the vaccine era: persistent burden and clinical implications. Clinical and Experimental Vaccine Research, 15(3), 187. https://doi.org/10.7774/cevr.2026.15.e18
Vancouver
Nwabueze C, Omeludike E, Lawal R, Nwabueze K. Hepatitis B in the vaccine era: persistent burden and clinical implications. Clinical and Experimental Vaccine Research. 2026;15(3):187. doi:10.7774/cevr.2026.15.e18
BibTeX
@article{Nwabueze2026,
author = {Nwabueze, Cherechi and Omeludike, Eunice and Lawal, Ridwan and Nwabueze, Kedife},
title = {Hepatitis B in the vaccine era: persistent burden and clinical implications},
journal = {Clinical and Experimental Vaccine Research},
year = {2026},
volume = {15},
number = {3},
pages = {187},
doi = {10.7774/cevr.2026.15.e18}
}
EUVIMED